Related Experiment Video
Updated: Jun 12, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children
N Schlegel1, V Bardet, G Kenet
1Service d'Hématologie Biologique, Hôpital Robert Debré, Paris, France.
Insights
Diagnosing inherited platelet function disorders in children requires understanding pediatric platelet physiology. This overview details diagnostic strategies and treatments for these rare bleeding conditions in early childhood.
Area of Science:
- Hematology
- Pediatric Medicine
- Rare Diseases
Background:
- Inherited platelet disorders cause bleeding syndromes of varying severity, often diagnosed in infancy or childhood.
- Accurate diagnosis in early childhood necessitates understanding pediatric platelet physiology.
- Thrombocytopenia is common in neonates and children, but this review focuses on inherited platelet function disorders.
Purpose of the Study:
- To provide an overview of inherited platelet function disorders in pediatric populations.
- To present age-specific platelet maturation and reference values.
- To outline a diagnostic strategy tailored for children, incorporating laboratory and molecular methods.
Main Methods:
- Review of current literature on pediatric platelet physiology and inherited disorders.
- Description of diagnostic approaches using plasmatic and molecular laboratory methodologies.
- Summary of therapeutic interventions for inherited platelet function disorders.
Main Results:
- Established the importance of age-specific knowledge for diagnosing pediatric platelet function disorders.
- Presented a diagnostic strategy adapted for the pediatric population.
- Summarized available therapeutic options, including antifibrinolytic agents, Desmopressin, HLA-matched platelets, and recombinant factor VIIa.
Conclusions:
- Accurate diagnosis of inherited platelet function disorders in children relies on understanding pediatric platelet physiology.
- A tailored diagnostic strategy combining laboratory and molecular methods is crucial for early detection.
- Various therapeutic approaches exist to manage these rare bleeding conditions in pediatric patients.
Abstract:
Inherited disorders of platelets constitute a group of rare diseases that give rise to bleeding syndromes of variety severity, with more severe cases being first diagnosed during infancy and childhood. To appropriate diagnose a platelet function disorder during early childhood the knowledge of the physiological characteristics of platelets in the paediatric population is mandatory. Apart from thrombocytopenia which is quite common in neonates and children the present overview is aimed to focus on inherited platelet function disorders. Furthermore, knowledge on platelet maturation and reference values according to age are given, and a diagnostic strategy specifically adapted to a pediatric population is presented on the bases of plasmatic and molecular laboratory methodologies. Finally, therapeutic approaches are briefly summarized (antifibrinolytic agents, Desmopressin, HLA-matched platelets, recombinant factor VIIa).
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...